Xcout Intel
Shorla Pharma competitors & alternatives
The 12 closest competitors and alternatives to Shorla Pharma among pharmaceuticals companies — ranked by similarity to what Shorla Pharma actually does, not by market-cap band.
Subscribe to see Shorla Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Shorla Pharma
Shorla Pharma (operating as Shorla Oncology) develops and commercializes innovative oncology drugs, focusing on indications where existing treatments are limited, in shortage, or inadequate. The company provides specialized cancer treatments and accessible pharmaceutical options for patients.
Shorla Pharma at a glance
Shorla Pharma is a pharmaceuticals company headquartered in Ireland. Xcout tracks 9 named people at Shorla Pharma, including Karlijn Kroon (Chief Medical Officer).
Shorla Pharma leadership
- Karlijn KroonChief Medical Officer
- SHEILA BHATTACHARYAChief Commercial Officer
- Sharon CunninghamCEO & Co-Founder
- Orlaith RyanCTO & Co-Founder
- Maurice ClancyVice President of Research and Development
- Vincent McDermottVice President of Quality and Regulatory Affairs
3 more named people on record for Shorla Pharma, with roles, board committees and tenure — see the full roster →
Top 12 Shorla Pharma competitors
Ranked by semantic similarity — how close each company is to Shorla Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology & Pharmaceuticals
Cancer Research Horizons is a specialist drug discovery, development, and commercialisation company that translates lab-bench innovations into diagnostics and treatments for cancer patients. The company collaborates with researchers, partners, and investors to advance oncology therapeutics, manage start-ups, and license research tools and data portfolios.
Similar pharmaceuticals company
Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancerous cells to radiation therapy. Its current portfolio of clinical-phase treatments features Ropidoxuridine, an orally administered halogenated pyrimidine, which is intended for individuals afflicted with brain tumors and soft tissue sarcomas. Additionally, the company is progressing Doranidazole, an injectable compound designed to make oxygen-deprived tumor cells more responsive to radiation, targeting malignancies of the pancreas, lungs, and liver. This enterprise was established in 2012 and maintains its principal operations in Rockville, Maryland.
Similar pharmaceuticals company
Deciphera Pharmaceuticals, LLC is a commercial-stage biopharmaceutical company dedicated to delivering transformational medicines, such as QINLOCK, to patients for the treatment of cancer and rare diseases.
Similar pharmaceuticals company
Searchlight Pharma Inc. is a specialty pharmaceutical company headquartered in Montreal, Quebec, committed to developing and commercializing innovative healthcare products.
Similar pharmaceuticals company
Servier is an international pharmaceutical company that researches, develops, and provides medical treatments primarily focused on oncology, cardio-metabolic diseases, and neurology. The company serves patients globally by delivering therapeutic innovations and advancing research in areas such as rare diseases and chronic conditions.
Biotechnology & Pharmaceuticals
SciTech Development L.L.C. is a clinical-stage specialty oncology pharmaceutical company that develops safer drug delivery platforms and targeted cancer therapeutics. The company's lead candidate, ST-001 nanoFenretinide, is a patented treatment designed for lymphoma and other cancer indications.
Similar pharmaceuticals company
Hyloris is a specialty biopharma company committed to addressing unmet medical needs through the development of pharmaceutical products and drug delivery solutions. It serves patients and healthcare providers by bringing innovative therapeutic options to the market.
Similar pharmaceuticals company
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Similar pharmaceuticals company
InnoCare Pharma is a China-focused biopharmaceutical company that discovers and develops innovative medicines, particularly for oncology and autoimmune diseases. It serves patients and healthcare providers through research, clinical development, and commercialization of targeted therapies.
Similar pharmaceuticals company
Hinova Pharma refers to Chongqing Hinova Pharmaceuticals Co., Ltd., a Chinese pharmaceutical company focused on discovering, developing, manufacturing, and commercializing small-molecule medicines, including oncology therapies. It serves patients through its own drug products and pharmaceutical partners through development and manufacturing capabilities.
Similar pharmaceuticals company
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Similar pharmaceuticals company
SK-Pharma is a global pharmaceutical company and supplier of medications, specializing in early generics, rare drugs, value-added generics, and specialty products such as orphan drugs and complex generics. The company focuses on improving drug accessibility, market monitoring, and supply chain optimization to serve patients worldwide.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Shorla Pharma and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Shorla Pharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →